Back
Mirati Therapeutics Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
20
MRTX
Mirati Therapeutics
Last Price:
39.81
Seasonality Move:
15.1%
Buy
55
BMY
Bristol-Myers Squibb
Last Price:
65.95
Seasonality Move:
0.56%
Sell
20
Mirati Therapeutics (MRTX)
is a Sell
Is Mirati Therapeutics a Buy, Sell or Hold?
- The current Mirati Therapeutics [MRTX] share price is $38.26. The Score for MRTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- MRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $65.66. The Score for BMY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRTX Stock Price Chart
What is Mirati Therapeutics's stock price today?
-
The Mirati Therapeutics share price today is $38.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $65.66
The current trend is relatively stagnant and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.68 | Sell |
| Relative Strength Index (14 RSI): | 34.95 | Sell |
| Chaikin Money Flow: | 929581 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.28 - 48.12) | Sell |
| Bollinger Bands (100): | (39.41 - 48.55) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.03 | Sell |
| Relative Strength Index (14 RSI): | 44.89 | Sell |
| Chaikin Money Flow: | 5343694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.04 - 68.14) | Sell |
| Bollinger Bands (100): | (66.71 - 71.99) | Sell |
MRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.49 | Sell |
| 20-day SMA: | 44.03 | Sell |
| 50-day SMA: | 41.97 | Sell |
| 200-day SMA: | 55.78 | Sell |
| 8-day EMA: | 39.44 | Sell |
| 20-day EMA: | 41.95 | Sell |
| 50-day EMA: | 43.06 | Sell |
| 200-day EMA: | 55.04 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.86 | Buy |
| 20-day SMA: | 66.41 | Sell |
| 50-day SMA: | 67.99 | Sell |
| 200-day SMA: | 71.56 | Sell |
| 8-day EMA: | 65.06 | Buy |
| 20-day EMA: | 66.04 | Sell |
| 50-day EMA: | 67.53 | Sell |
| 200-day EMA: | 70.36 | Sell |
Mirati Therapeutics Earnings Growth & MRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $1.67 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.15 per share, an increase this year of $0.43 per share, and an increase next year of $0.11 per share.
Mirati Therapeutics Technical Analysis
| May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||